about
Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus.Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.Entecavir plus adefovir combination therapy versus lamivudine add-on adefovir for lamivudine-resistant chronic hepatitis B: A meta-analysis.Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection.Interferon-stimulated gene 20 kDa protein serum levels and clinical outcome of hepatitis B virus-related liver diseases.Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The Role of Interferon in Hepatitis B Therapy.
@ast
The Role of Interferon in Hepatitis B Therapy.
@en
The Role of Interferon in Hepatitis B Therapy.
@nl
type
label
The Role of Interferon in Hepatitis B Therapy.
@ast
The Role of Interferon in Hepatitis B Therapy.
@en
The Role of Interferon in Hepatitis B Therapy.
@nl
prefLabel
The Role of Interferon in Hepatitis B Therapy.
@ast
The Role of Interferon in Hepatitis B Therapy.
@en
The Role of Interferon in Hepatitis B Therapy.
@nl
P2860
P1476
The Role of Interferon in Hepatitis B Therapy.
@en
P2093
Harry L A Janssen
Vincent Rijckborst
P2860
P304
P356
10.1007/S11901-010-0055-1
P577
2010-08-26T00:00:00Z